| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.28B | 137.98B | 137.18B | 130.04B | 122.75B | 137.65B |
| Gross Profit | 40.63B | 38.64B | 37.86B | 35.58B | 33.58B | 35.27B |
| EBITDA | 8.10B | 7.99B | 7.95B | 7.42B | 6.05B | 7.49B |
| Net Income | 4.16B | 2.65B | 4.13B | 3.58B | 1.61B | 3.90B |
Balance Sheet | ||||||
| Total Assets | 59.92B | 56.48B | 57.70B | 52.18B | 47.34B | 48.69B |
| Cash, Cash Equivalents and Short-Term Investments | 15.61B | 10.15B | 13.46B | 12.69B | 9.04B | 11.58B |
| Total Debt | 14.56B | 9.93B | 12.75B | 11.80B | 11.64B | 12.19B |
| Total Liabilities | 32.69B | 27.25B | 30.84B | 28.90B | 27.27B | 29.14B |
| Stockholders Equity | 27.23B | 29.23B | 26.86B | 23.27B | 20.07B | 19.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 353.00M | 1.55B | 3.63B | -661.00M | 2.86B |
| Operating Cash Flow | 0.00 | 5.27B | 5.27B | 7.36B | 3.33B | 6.13B |
| Investing Cash Flow | 0.00 | -5.00B | -3.05B | -3.29B | -4.20B | -3.27B |
| Financing Cash Flow | 0.00 | -3.55B | -1.45B | -423.00M | -1.68B | -1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥31.54B | 9.72 | ― | 1.94% | 2.76% | 24.96% | |
73 Outperform | ¥164.17B | 19.91 | ― | 1.39% | 2.98% | 0.84% | |
65 Neutral | ¥27.55B | 10.33 | ― | 3.23% | 0.38% | -41.74% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥125.63B | 14.71 | ― | 3.02% | 3.24% | -7.55% | |
61 Neutral | ¥49.66B | 3.77 | ― | 0.52% | 1.84% | -0.45% | |
55 Neutral | ¥25.55B | 13.06 | ― | 1.93% | 0.59% | -36.07% |